Chemed Co. (NYSE:CHE) Shares Sold by Martingale Asset Management L P

Martingale Asset Management L P decreased its holdings in Chemed Co. (NYSE:CHE) by 12.1% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 28,132 shares of the company’s stock after selling 3,861 shares during the quarter. Martingale Asset Management L P owned 0.19% of Chemed worth $14,904,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of CHE. State Street Corp grew its holdings in shares of Chemed by 0.8% in the 3rd quarter. State Street Corp now owns 464,354 shares of the company’s stock worth $279,063,000 after acquiring an additional 3,564 shares during the last quarter. Geode Capital Management LLC increased its stake in Chemed by 1.5% in the 4th quarter. Geode Capital Management LLC now owns 340,409 shares of the company’s stock worth $180,654,000 after purchasing an additional 4,966 shares in the last quarter. FMR LLC lifted its stake in Chemed by 18.9% during the fourth quarter. FMR LLC now owns 283,790 shares of the company’s stock valued at $150,352,000 after buying an additional 45,174 shares in the last quarter. JPMorgan Chase & Co. boosted its holdings in shares of Chemed by 8.2% in the fourth quarter. JPMorgan Chase & Co. now owns 266,786 shares of the company’s stock worth $141,343,000 after buying an additional 20,310 shares during the period. Finally, Boston Trust Walden Corp increased its position in shares of Chemed by 10.0% in the fourth quarter. Boston Trust Walden Corp now owns 242,172 shares of the company’s stock worth $128,303,000 after acquiring an additional 22,105 shares in the last quarter. Institutional investors own 95.85% of the company’s stock.

Chemed Stock Performance

Chemed stock opened at $571.72 on Wednesday. The firm’s 50 day moving average price is $580.74 and its two-hundred day moving average price is $567.86. The firm has a market cap of $8.37 billion, a PE ratio of 28.89, a P/E/G ratio of 2.15 and a beta of 0.49. Chemed Co. has a twelve month low of $512.12 and a twelve month high of $627.12.

Chemed Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Monday, February 24th were given a dividend of $0.50 per share. The ex-dividend date of this dividend was Monday, February 24th. This represents a $2.00 dividend on an annualized basis and a yield of 0.35%. Chemed’s payout ratio is 10.05%.

Analyst Upgrades and Downgrades

CHE has been the subject of a number of recent analyst reports. StockNews.com raised shares of Chemed from a “hold” rating to a “buy” rating in a research note on Friday, March 7th. Royal Bank of Canada increased their price objective on Chemed from $633.00 to $667.00 and gave the stock an “outperform” rating in a research note on Friday, March 14th.

Insider Buying and Selling at Chemed

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction that occurred on Thursday, March 6th. The stock was sold at an average price of $593.67, for a total value of $1,187,340.00. Following the completion of the sale, the chief executive officer now owns 102,679 shares of the company’s stock, valued at approximately $60,957,441.93. The trade was a 1.91 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Corporate insiders own 3.32% of the company’s stock.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.